We are live on ! Find out more
BCP

BlackBarn Capital Partners Portfolio holdings

AUM $1.19B
1-Year Est. Return 63.92%
This Fund
S&P 500
This Quarter Est. Return
+16.46%
1 Year Est. Return
+63.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.52B
AUM Growth
+$124M
Cap. Flow
-$62.4M
Cap. Flow %
-4.11%
Top 10 Hldgs %
94.18%
Holding
21
New
1
Increased
10
Reduced
5
Closed
5

Sector Composition

Rank Sector Weight
1 Miscellaneous 83.74%
2 Healthcare 9.59%
3 Technology 2.46%
4 Utilities 1.77%
5 Consumer Staples 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$1.02B 67.27%
1,500,000
+250,000
+20% +$169M
RMD icon
2
PUT
ResMed
RMD
$31.5B
$96.3M 6.34%
400,000
-300,000
-43% -$76.7M
ROIV icon
3
Roivant Sciences
ROIV
$29.5B
$66.9M 4.4%
3,084,300
-1,315,700
-30% -$26M
WRBY icon
4
PUT
Warby Parker
WRBY
$3.05B
$65.4M 4.3%
3,000,000
+2,000,000
+200% +$43.5M
ELAN icon
5
PUT
Elanco Animal Health
ELAN
$11.6B
$38.5M 2.53%
1,700,000
+950,000
+127% +$20.7M
DHC
6
Diversified Healthcare Trust
DHC
$1.82B
$31.7M 2.08%
6,530,140
+380,140
+6% +$1.72M
PRVA icon
7
Privia Health
PRVA
$2.61B
$30.8M 2.03%
1,300,000
+209,618
+19% +$5.1M
NIQ
8
NIQ Global Intelligence PLC
NIQ
$5.26B
$29.7M 1.95%
+1,800,000
New +$26.3M
NEE icon
9
NextEra Energy
NEE
$172B
$26.9M 1.77%
335,000
+65,000
+24% +$5.38M
MH
10
McGraw Hill
MH
$2.36B
$23.1M 1.52%
1,400,000
+549,243
+65% +$7.97M
AMRX icon
11
Amneal Pharmaceuticals
AMRX
$5.92B
$19.8M 1.3%
1,570,000
-619,452
-28% -$7.09M
VKTX icon
12
Viking Therapeutics
VKTX
$3.73B
$19.3M 1.27%
550,000
+50,000
+10% +$1.77M
OSCR icon
13
PUT
Oscar Health
OSCR
$10.1B
$18.7M 1.23%
1,300,000
+50,000
+4% +$865K
CCOI icon
14
Cogent Communications
CCOI
$478M
$14M 0.92%
650,000
+275,000
+73% +$8.12M
ABUS icon
15
Arbutus Biopharma
ABUS
$1.01B
$8.9M 0.59%
1,850,000
-150,000
-8% -$674K
ACLS icon
16
Axcelis
ACLS
$3.5B
$7.76M 0.51%
96,573
-103,427
-52% -$8.66M
BVFL icon
17
BV Financial
BVFL
$177M
-291,442
Closed -$4.7M
MOH icon
18
Molina Healthcare
MOH
$10.7B
-95,000
Closed -$18.2M
NXT icon
19
Nextpower Inc. Common Stock
NXT
$12.6B
-350,000
Closed -$25.9M
TEVA icon
20
Teva Pharmaceuticals
TEVA
$43.2B
-1,000,000
Closed -$20.2M
FBLA
21
FB Bancorp
FBLA
$232M
-624,700
Closed -$7.51M

Similar funds

BlackBarn Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, BlackBarn Capital Partners held 21 positions worth $1.52B, up 8.8% from $1.4B the previous quarter. Its ten largest holdings account for 94% of the portfolio.

BlackBarn Capital Partners withdrew a net $62.4M in Q4 2025, closing 5 positions and reducing 5 holdings. Its most notable exit was Nextpower Inc. Common Stock, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, up from 80% a quarter earlier, followed by Healthcare and Technology.

Against the trend, BlackBarn Capital Partners opened a new position in NIQ Global Intelligence PLC worth $29.7M.

  • BlackBarn Capital Partners's largest Q4 2025 buy was NIQ Global Intelligence PLC: 1,800,000 shares worth $29.7M.
  • BlackBarn Capital Partners added most to Cogent Communications in Q4 2025, an estimated $8.12M increase.
  • BlackBarn Capital Partners's biggest Q4 2025 reduction was Roivant Sciences, cutting an estimated $26M.
  • BlackBarn Capital Partners fully exited Nextpower Inc. Common Stock in Q4 2025, selling an estimated $25.9M.
  • BlackBarn Capital Partners's ten largest holdings make up 94% of its $1.52B portfolio in Q4 2025.
  • BlackBarn Capital Partners opened 1 new position and closed 5 in Q4 2025.
  • BlackBarn Capital Partners's portfolio value rose 8.8% quarter-over-quarter to $1.52B.

Based on BlackBarn Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.